Johnson & Johnson (BUE:JNJ) Cyclically Adjusted Book per Share: ARS3,377.58 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:JNJ Johnson & Johnson BUE:JNJ
74 GF Score
Price ARS28,400.00
GF Value ARS20,480.68
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Cyclically Adjusted Book per Share?

Johnson & Johnson BUE:JNJ +1.21% 74 Cyclically Adjusted Book per Share is ARS3,377.58 as of Jun. 2026. GuruFocus rates BUE:JNJ with a GF Score™ of 74/100 and a GF Value™ of ARS20,480.68 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Johnson & Johnson's adjusted book value per share for the three months ended in Jun. 2026 was ARS10,452.441. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS3,377.58 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted Book Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Johnson & Johnson was 14.50% per year. The lowest was 1.70% per year. And the median was 10.60% per year.

As of today (2026-07-28), Johnson & Johnson's current stock price is ARS28400.00. Johnson & Johnson's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ARS3,377.58. Johnson & Johnson's Cyclically Adjusted PB Ratio of today is 8.41.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 8.22. The lowest was 4.60. And the median was 5.48.


Johnson & Johnson  (BUE:JNJ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=28400.00/3377.58
=8.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 8.22. The lowest was 4.60. And the median was 5.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Johnson & Johnson Cyclically Adjusted Book per Share Related Terms


Johnson & Johnson Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Cyclically Adjusted Book per Share Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,150.38 685.73 1,977.89 2,416.61 3,203.02

Johnson & Johnson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,549.53 3,246.25 3,203.02 3,140.56 3,377.58

BUE:JNJ vs ABBV, MRK, LLY: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PB Ratio falls into.


BUE:JNJ
74GF Score
Johnson & Johnson BUE:JNJ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10452.441/333.9520*333.9520
=10,452.441

Current CPI (Jun. 2026) = 333.9520.

Johnson & Johnson Quarterly Data

Book Value per Share CPI Adj_Book
201609 79.739 241.428 110.298
201612 82.490 241.432 114.101
201703 80.481 243.801 110.241
201706 88.325 244.955 120.415
201709 96.565 246.819 130.655
201712 85.647 246.524 116.021
201803 95.036 249.554 127.177
201806 116.948 251.989 154.987
201809 177.267 252.439 234.507
201812 169.247 251.233 224.972
201903 173.559 254.202 228.009
201906 205.583 256.143 268.033
201909 247.472 256.759 321.873
201912 270.069 256.974 350.970
202003 289.051 258.115 373.977
202006 327.573 257.797 424.340
202009 363.691 260.280 466.633
202012 391.228 260.474 501.591
202103 450.513 264.877 567.998
202106 500.862 271.696 615.629
202109 522.031 274.310 635.534
202112 568.709 278.802 681.206
202203 610.155 287.504 708.729
202206 698.967 296.311 787.758
202209 792.205 296.808 891.345
202212 985.323 296.797 1,108.672
202303 1,077.631 301.836 1,192.293
202306 1,388.358 305.109 1,519.604
202309 2,070.993 307.789 2,247.034
202312 2,062.867 306.746 2,245.827
202403 4,902.255 312.332 5,241.595
202406 5,323.338 314.175 5,658.437
202409 5,540.251 315.301 5,867.973
202412 5,999.771 315.605 6,348.554
202503 6,922.698 319.799 7,229.068
202506 7,741.945 322.561 8,015.346
202509 8,948.497 324.800 9,200.642
202512 9,830.832 324.054 10,131.108
202603 9,433.943 330.213 9,540.763
202606 10,452.441 333.952 10,452.441

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ARS3,377.58 mean?
Johnson & Johnson (BUE:JNJ) has a Cyclically Adjusted Book per Share of ARS3,377.58 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Cyclically Adjusted Book per Share too high?
Johnson & Johnson's current Cyclically Adjusted Book per Share is ARS3,377.58. Overall, Johnson & Johnson has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Cyclically Adjusted Book per Share compare to ABBV and MRK?
Johnson & Johnson's Cyclically Adjusted Book per Share of ARS3,377.58 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Cyclically Adjusted Book per Share is ARS3,377.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (BUE:JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS20,480.68, compared to a current price of ARS28,400.00 — trading 38.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is ARS3,377.58. Johnson & Johnson's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Johnson & Johnson (BUE:JNJ), the current Cyclically Adjusted Book per Share is ARS3,377.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (BUE:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of ARS28,400.00 is trading 38.7% above its estimated GF Value™ of ARS20,480.68. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for BUE:JNJ:

  • Cyclically Adjusted Book per Share: ARS3,377.58
  • GF Value™: ARS20,480.68 vs. price of ARS28,400.00 (38.7% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the BUE:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
74GF Score

Get the complete analysis for BUE:JNJ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS28,400.00
Price
ARS20,480.68
GF Value